Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Pharma Talk Radio

PharmaTalkRadio

×  

Follow This Show

Stay in the know about new episodes and updates.
Guest hosts interview industry insiders on strategies, business models, leadership, technologies & innovations in advancing drug development for the benefit of patients. More specifically: clinical trials, patient-centricity, mobile/digital in R&D, drug delivery, emerging biotechs and Immuno-Oncology. PharmaTalkRadio is a non-profit program to provide easy and free access of helpful information for professionals in life sciences as well as patient advocates. It is organized and supported by the Conference Forum.

On-Demand Episodes

Moderated by Marian Gindy, PhD, Executive Director, Discovery Pharmaceutical Sciences, Merck, this panel discussion recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference explores how mRNA... more

This session was presented at the 8th annual DPharm conference in September 2018. When Amazon announced that the creation of a new healthcare company with Berkshire Hathaway and JPMorgan Chase, the move signaled how the... more

Roughly, 5.7 million people in the U.S. are living with Alzheimer's. Globally, an estimated 47 million individuals are living with dementia. There is no cure, and treatments can only relieve certain symptoms for some people. Research... more

This 8 minute podcast summarizes what you can expect at the 4th annual IO Combinations 360° conference. This conference provides the latest data impacting immuno-oncology combinations and patient treatment with... more

Dr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, Department of Medicine and Center for Cellular Immunotherapies (CCI), Perelman School of Medicine, University of... more

The hardest thing to figure out now is what interventions and combinations make the most sense in which patients and how to combine all these emerging modalities in a way that is cost effective, benefits patients and unfolds in our... more

In this panel, moderated by Dr Axel Hoos, GSK, individuals from large pharma and biotech business development leads discuss decision-making when it comes to partnering and collaborations in today's IO environment. What is the... more

This panel, moderated by Dr Priti Hegde, Genentech, discusses the following: How can biomarkers act as a tool for understanding the biology at a level that is sufficient for making decisions around combinations? What are the potential... more

In this podcast, Dr Gregory Goldmacher, Executive Director, Translational Biomarkers and Head of Clinical Imaging, Merck Research Labs along with Dr Matthew Silva, Executive Vice President, Scientific Applications, Invicro discuss... more

The 2nd annual Drug Delivery West (DDW) Summit provides a west coast venue for biotech, pharma and drug delivery companies to address scientific and business solutions for the best routes of delivery across different therapeutic... more

Comments

 comments